151 related articles for article (PubMed ID: 15061212)
21. Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2'-deoxycytidine (Decitabine).
Farinha NJ; Shaker S; Lemaire M; Momparler L; Bernstein M; Momparler RL
Anticancer Res; 2004; 24(1):75-8. PubMed ID: 15015578
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells.
Momparler RL; Côté S; Momparler LF; Idaghdour Y
Front Oncol; 2017; 7():19. PubMed ID: 28261562
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.
Momparler RL; Côté S; Momparler LF; Idaghdour Y
Clin Epigenetics; 2014; 6(1):19. PubMed ID: 25313314
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells.
Doré BT; Momparler RL
Anticancer Drugs; 1992 Jun; 3(3):281-7. PubMed ID: 1381972
[TBL] [Abstract][Full Text] [Related]
25. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
Bovenzi V; Momparler RL
Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527
[TBL] [Abstract][Full Text] [Related]
26. Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase.
Momparler RL; Doré BT; Labiberté J; Momparler LF
Leukemia; 1993 May; 7 Suppl 1():17-20. PubMed ID: 7683351
[TBL] [Abstract][Full Text] [Related]
27. [5-Aza-2'-deoxycytidine enhances differentiation and apoptosis induced by phenylbutyrate in Kasumi-1 cells].
Hao CL; Tang KJ; Chen S; Xing HY; Wang M; Wang JX
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):148-51. PubMed ID: 15946563
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
Wilson VL; Jones PA; Momparler RL
Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
[TBL] [Abstract][Full Text] [Related]
29. Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine.
Momparler RL; Bouchard J; Samson J
Leuk Res; 1985; 9(11):1361-6. PubMed ID: 2417065
[TBL] [Abstract][Full Text] [Related]
30. Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL; Doré BT; Momparler LF
Cancer Lett; 1990 Oct; 54(1-2):21-8. PubMed ID: 1698532
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).
Momparler RL
Semin Oncol; 2005 Oct; 32(5):443-51. PubMed ID: 16210084
[TBL] [Abstract][Full Text] [Related]
32. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
Momparler RL; Laliberté J
Leuk Res; 1990; 14(9):751-4. PubMed ID: 1700230
[TBL] [Abstract][Full Text] [Related]
33. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
Momparler RL; Bouchard J; Onetto N; Rivard GE
Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines.
Hurtubise A; Momparler RL
Anticancer Drugs; 2004 Feb; 15(2):161-7. PubMed ID: 15075673
[TBL] [Abstract][Full Text] [Related]
35. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro.
Veselý J
Int J Cancer; 1982 Jan; 29(1):81-5. PubMed ID: 6174463
[TBL] [Abstract][Full Text] [Related]
38. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
39. Antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells.
Shaker S; Bernstein M; Momparler RL
Oncol Rep; 2004 Jun; 11(6):1253-6. PubMed ID: 15138563
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).
Momparler RL
Semin Hematol; 2005 Jul; 42(3 Suppl 2):S9-16. PubMed ID: 16015507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
